Cited by 810Cancer-related Molecular PathwaysCell death mechanisms and regulationGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

p53 isoforms can regulate p53 transcriptional activity

Open access

Bourdon, Jean-Christophe, Fernandes, Kenneth, Murray-Zmijewski, Fiona, Liu, Geng, Diot, Alexandra, Xirodimas, Dimitris P., Saville, Mark K., Lane, David P.·2005·Genes & Development

DOI 10.1101/gad.1339905PMC PMC1221884

Open this paper in CoChat — free account Open PDF

Abstract

The recently discovered p53-related genes, p73 and p63, express multiple splice variants and N-terminally truncated forms initiated from an alternative promoter in intron 3. To date, no alternative promoter and multiple splice variants have been described for the p53 gene. In this study, we show that p53 has a gene structure similar to the p73 and p63 genes. The human p53 gene contains an alternative promoter and transcribes multiple splice variants. We show that p53 variants are expressed in normal human tissue in a tissue-dependent manner. We determine that the alternative promoter is conserved through evolution from Drosophila to man, suggesting that the p53 family gene structure plays an essential role in the multiple activities of the p53 family members. Consistent with this hypothesis, p53 variants are differentially expressed in human breast tumors compared with normal breast tissue. We establish that p53β can bind differentially to promoters and can enhance p53 target gene expression in a promoter-dependent manner, while Δ133p53 is dominant-negative toward full-length p53, inhibiting p53-mediated apoptosis. The differential expression of the p53 isoforms in human tumors may explain the difficulties in linking p53 status to the biological properties and drug sensitivity of human cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.1339905

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Self-citation
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,085
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.
DeLeo, A. B., Jay, G. D., Appella, E., DuBois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721
Modulation of mammalian life span by the short isoform of p53
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586
Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity
Xirodimas, D. P., Saville, M. K., Bourdon, J.-C., Hay, R. T., & Lane, D. P. (2004) · Cell · doi:10.1016/j.cell.2004.06.016 · Cited by 570
Self-citation
On the shoulders of giants: p63, p73 and the rise of p53
Yang, A., Kaghad, M., Caput, D., & McKeon, F. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02595-7 · Cited by 496
Drosophila p53 Binds a Damage Response Element at the reaper Locus
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 474

Flagged first, then by citations

Show all 43 references

Research works printed but not linked: 7

1996, Oncogene, 12, 813
1986, Mol. Cell. Biol., 6, 1379
2003, Cell Death Differ., 1, 431
1995, Oncogene, 10, 1865
1995, Oncogene, 10, 389
1985, Mol. Cell. Biol., 5, 127
2003, Cancer Res., 63, 2351

Sorted by citations

Items 601–700 of 807

Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregationPreprint
Zhao, L., Punga, T., & Sanyal, S. (2025) · eLife · doi:10.7554/elife.106469 · Cited by 6
Alternative Splicing: Emerging Roles in Anti-Aging Strategies
Gao, L., & Jia, R. (2025) · Biomolecules · doi:10.3390/biom15010131 · Cited by 5
Role of artificial intelligence in cancer detection using protein p53: A Review
Patil, M. R., & Bihari, A. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10051-4 · Cited by 6
Characterization of a spliced variant of human IRF-3 promoter and its regulation by the transcription factor Sp1
Ren, W., Zhu, L.-H., Xu, H., Jin, R., & Zhou, G. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1528-9 · Cited by 5
Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline
Kratz, C. P., Steinke‐Lange, V., Spier, I., Aretz, S., Schröck, E., & Holinski‐Feder, E. (2021) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1541-7912 · Cited by 5
Allelic loss at TP53 in metastatic human endometrial carcinomas
Szewczuk, W., Skomra, D. G., Cybulski, M., Prządka-Rabaniuk, D., Filip, A. A., Jóźwik, M., Olcha, P., Roessner, A., & Semczuk, A. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9278-3 · Cited by 5
Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma
Anselmo, N. P., REY, J. A., Almeida, L. O., Cust�dio, A. C., Almeida, J. R. W., Clara, C., dos Santos, M. J., & Casartelli, C. (2009) · Genetics and Molecular Research · doi:10.4238/vol8-4gmr631 · Cited by 5
Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms and their haplotypes in susceptibility to sarcopenia in Iranian older adults
Montazeri‐Najafabady, N., Dabbaghmanesh, M. H., Nasimi, N., Sohrabi, Z., Estedlal, A., & Asmarian, N. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02765-6 · Cited by 5
Study of P53 Gene Mutations as a New Early Diagnostic Markers of Hepatocellular Carcinoma in Egyptian Patients
Elhameed, A. H. A., Abo-Elenein, A., Ibrahim, W., El-kassas, G., & Noweir, M. (2018) · Madridge Journal of Oncogenesis · doi:10.18689/mjo-1000104 · Cited by 5
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment
Popek-Marciniec, S., Styk, W., Wojcierowska-Litwin, M., Chocholska, S., Szudy‐Szczyrek, A., Samardakiewicz, M., Świderska-Kołacz, G., Czerwik-Marcinkowska, J., & Zmorzyński, S. (2023) · Cancers · doi:10.3390/cancers15194747 · Cited by 5
Non-hominid TP63 lacks retroviral LTRs but contains a novel conserved upstream exon
Beyer, U., & Dobbelstein, M. (2011) · Cell Cycle · doi:10.4161/cc.10.12.15838 · Cited by 5
The Balance between p53 Isoforms Modulates the Efficiency of HIV-1 Infection in Macrophages
Breton, Y., Barat, C., & Tremblay, M. J. (2021) · Journal of Virology · doi:10.1128/jvi.01188-21 · Cited by 5
p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partnersPreprint
Brdar, A., Osterburg, C., Münick, P., Machel, A. C., Rathore, R., Osterburg, S., Yüksel, B., Schäfer, B., Desch, K., Langer, J. D., et al. (2024) · eLife · doi:10.7554/elife.103537 · Cited by 5
A Quantitative High-Throughput Screen Identifies Compounds that Upregulate the p53 Isoform Δ133p53α and Inhibit Cellular Senescence
Lissa, D., Joruiz, S. M., Dranchak, P. K., Ungerleider, K., Yamada, L., Horikawa, I., Oliphant, E. N., Manubag, R., von Muhlinen, N., Beck, J. A., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00186 · Cited by 5
p53 represses the transcription of snRNA genes by preventing the formation of little elongation complex
Anwar, D., Takahashi, H., Watanabe, M., Suzuki, M., Fukuda, S., & Hatakeyama, S. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.06.001 · Cited by 4
Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer
Qadir, J., Majid, S., Khan, M. S., Rashid, F., Wani, M. D., & Bhat, S. A. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609826 · Cited by 4
Ubiquitin Family Members in the Regulation of the Tumor Suppressor p53
Xirodimas, D. P., & Scheffner, M. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_10 · Cited by 5
Self-citation
Functional cross-talk between p73β and NF-κB mediated by p300
Ryou, S.-M., Kang, K.-H., Jeong, M.-H., Kim, J.-W., An, J., Lee, S., Jang, S., Song, P. I., & Choi, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.120 · Cited by 4
p53 splice variants generated by atypical mRNA processing confer complexity of p53 transcripts in the human brain
Nikoshkov, A., & Hurd, Y. L. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.029 · Cited by 4
Glycolytic flux occurs in Drosophila melanogaster recovering from camptothecin treatment
Hull, R., & Ntwasa, M. M. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833e2f60 · Cited by 4
The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient
Li, Y., Li, T., Tang, Y., Zhan, Z., Ding, L., Song, L., Yu, T., Yang, Y., Ma, J., Zhang, Y., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234262 · Cited by 4
Δ113p53/Δ133p53: survival and integrity
Chen, J., & Peng, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4371 · Cited by 4
New mutations in the human p53 gene — a regulator of the cell cycle and carcinogenesis
Кашкин, К. Н., Khlgatian, S. V., Гурова, О. В., Kuprash, D. V., & Недоспасов, С. А. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907030054 · Cited by 4
Exploring p53 isoforms: unraveling heterogeneous p53 tumor suppressor functionality in uveal melanoma
Bartolomei, L., Ciribilli, Y., Brugnara, S., Reggiani, F., Moretta, G. M., Petito, M., Marcaccini, E., Ambrosio, M., Mosci, C., Pfeffer, U., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02891-1 · Cited by 3
Interaction of C-terminal p53 isoforms depends strongly upon DNA sequence and topology
Goswami, P., Šislerová, L., Dobrovolná, M., Havlík, J., Šťastný, J., & Brázda, V. (2022) · Biochimie · doi:10.1016/j.biochi.2022.12.011 · Cited by 3
Cr (VI) induces lactate utilization through HIF-1α/MCT1 dependent on p53 protein level
Li, S., Guo, Y., Cui, X., Li, L., Fan, J., & Cao, J. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115505 · Cited by 3
Splice-acceptor site mutation in p53 gene of hu888 zebrafish line
Piasecka, A., Brzuzan, P., Woźny, M., Ciesielski, S., & Kaczmarczyk, D. (2014) · Journal of Applied Genetics · doi:10.1007/s13353-014-0239-4 · Cited by 3
Effect of p53β on human gastric cancer cells treated with recombinant mutated human TNF and cisplatin
Ji, W., Yuan, M., Zhang, L., Zhang, H., Jiao, J., & Gao, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6436 · Cited by 3
Studying The Expression of Human P53 Gene in Patients Carrying Breast Cancer.
Edan, D. S. (2017) · Al-Mustansiriyah Journal of Sciences · doi:10.23851/mjs.v28i1.240 · Cited by 3
p53-dependent cell cycle checkpoint after DNA damage and its relevance to PARP1
Nozaki, T., & Masutani, M. (2018) · Research and Review Insights · doi:10.15761/rri.1000137 · Cited by 3
Translation of human Δ133p53 mRNA and its targeting by antisense oligonucleotides complementary to the 5′-terminal region of this mRNA
Żydowicz-Machtel, P., Dutkiewicz, M., Świątkowska, A., Gurda, D., & Ciesiołka, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256938 · Cited by 3
A Novel Role of SMG1 in Cholesterol Homeostasis That Depends Partially on p53 Alternative Splicing
Li, M., Philantrope, F., Diot, A., Bourdon, J., & Thompson, P. A. (2022) · Cancers · doi:10.3390/cancers14133255 · Cited by 3
Self-citation
A Narrative Review of the TP53 and Its Product the p53 Protein
Foroutan, B. (2023) · OBM Genetics · doi:10.21926/obm.genet.2302185 · Cited by 8
Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas
Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Rakotopare, J., Vaysse-Zinkhöfer, W., Eldawra, E., et al. (2024) · eLife · doi:10.7554/elife.92774 · Cited by 4
Self-citation
Li-Fraumeni syndrome: a germline TP53 splice variant reveals a novel physiological alternative transcript
Louis, J., Rolain, M., Levacher, C., Baudry, K., Pujol, P., Ruminy, P., Baert‐Desurmont, S., Bou, J., Bouvignies, E., Coutant, S., et al. (2025) · Journal of Medical Genetics · doi:10.1136/jmg-2024-110449 · Cited by 2
Sensitivity to tumor development by TALEN-mediated Trp53 mutant genes in the susceptible FVB/N mice and the resistance C57BL/6 mice
Yun, W. B., Kim, J. E., Lee, M. L., Choi, J. Y., Park, J. J., Song, B., Kang, B. C., Nam, K. T., Lee, H., & Hwang, D. Y. (2021) · Laboratory Animal Research · doi:10.1186/s42826-021-00107-y · Cited by 3
p53β isoform modulates differentially p53 transcriptional activity in response to stress
Fernandes, K., & Bourdon, J. (2008) · Breast Cancer Research · doi:10.1186/bcr1896 · Cited by 3
Self-citation
DNA repair, damage signaling and carcinogenesis
Lavelle, C., Salles, B., & Wiesmüller, L. (2008) · DNA repair · doi:10.1016/j.dnarep.2007.12.007 · Cited by 3
Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome
Taja‐Chayeb, L., Vidal-Millán, S., Gutiérrez, O., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Chávez-Blanco, A. D., la Cruz-Hernández, E. N. D., & Dueñas‐González, A. (2009) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-7-97 · Cited by 3
A Comparison of p53 Isoform Profiles and Apoptosis Induced by Camptothecin or a Herbal Khat Extract (Catha Edulis (Vahl) Forssk. ex Endl.) in Leukemic Cell Lines: Exploring Cellular Responses in Therapy Development
Onyango, T. B., Hjelle, S. M., Haaland, I., Vintermyr, O. K., Johannessen, A. C., & Gjertsen, B. T. (2020) · Cancers · doi:10.3390/cancers12123596 · Cited by 3
Activation of P53 pathway contributes to Xenopus hybrid inviability
Shi, Z., Liu, G., Jiang, H., Shi, S., Zhang, X., Deng, Y., & Chen, Y. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303698120 · Cited by 2
Self-citation
ΔN-p73: the enemy within
Salomoni, P., & Dyer, M. J. S. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401802 · Cited by 3
Characterization of the E3 Ubiquitin Ligase Pirh2
Tai, E. (2010) · TSpace (University of Toronto) · Cited by 3
Stress response to genotoxic agents and to infection
Hull, R. (2012) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 3
NOTCH1 dimeric signaling is essential for T-cell leukemogenesis and leukemia maintenance
Tamiro, F., Padovano, C., Santis, E. D., Iasio, S. D., Sansico, D. F., Canistro, V., Colucci, M., Nunzio, C. D., Bruno, G., Doshi, K., et al. (2025) · Blood · doi:10.1182/blood.2024027020 · Cited by 2
Tumor protein 53 gene polymorphism, demographic attributes and associated risk factors among liver cancer patients in Calabar, Nigeria
Ekpenyong, B. B., Ubi, G. M., Kooffreh, M., Umoyen, A. J., James, C. S., Ettah, I. A., Etangetuk, N. A., Effiom, B. E., Okpechi, P. A., Ejue, B. J., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13803-y · Cited by 2
Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
Zhao, L., Punga, T., & Sanyal, S. (2025) · eLife · doi:10.7554/elife.106469.2 · Cited by 8
Role of p53 family members during development of striated muscle, with focus on p63
Ziermann, J. M., Boughner, J. C., & McPike, K. N. (2025) · Developmental Dynamics · doi:10.1002/dvdy.70077 · Cited by 2
p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?
Bartolomei, L., Pretto, B., Brugnara, S., Sontacchi, A., Dassi, V., Bousrih, A., Damaggio, C., Flangini, F., Bisio, A., & Ciribilli, Y. (2026) · Cancers · doi:10.3390/cancers18071057 · Cited by 3
Regulation of Eukaryotic Gene Expression Through Functional Coupling Between Alternative Splicing and Nonsense-mediated Decay
Yap, K., Ramakumar, S., Hamid, F., & Makeyev, E. V. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169764 · Cited by 2
Methylation of the Selected TP53 Introns in Advanced-Stage Ovarian Carcinomas
Szewczuk, W., Szewczuk, O., Czajkowski, K., Gromadka, R., Man, Y.-G., Walędziak, M. S., & Semczuk, A. (2024) · Journal of Cancer · doi:10.7150/jca.94945 · Cited by 2
Molecular signaling and clinical implications in the human aging-cancer cycle
Rezaeian, A.-H., & Wei, W. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.08.003 · Cited by 2
An Isoform-Specific RUNX1C–BTG2 Axis Governs AML Quiescence and Chemoresistance
Han, C., Zhang, Z., Crosse, E. I., Sajedi, S., Lü, B., Wang, X., Karma, S., Kostich, M. S., Rajendran, S. H., Udy, D. B., et al. (2025) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0327 · Cited by 2
TP53 Mutations and Chemotherapy Response to Neoadjuvant Metotrexate, Cisplatin and Adryamicin Chemotherapy in Resected Osteosarcoma
Richter, L., Buzzi, M., & Dantas-Barbosa, C. (2013) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2013.412a1008 · Cited by 2
SuPr‐1‐mediated desumoylation regulates the repressor activity of ΔNp63α
Lee, H., Cho, M., Lee, J.-H., Kim, H.-S., Yun, Y., & Lee, H. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.013 · Cited by 2
Investigating Cancer-related Proteins Specific Domain Interactions and Differential Protein Interactions Caused by Alternative Splicing
Lee, Y.-L., Weng, J.-W., Chiang, W.-C., Lin, Y.-W., Ng, K., Tsai, J., & Huang, C. F. (2011) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2011.12 · Cited by 2
Applications of p53 interactome analysis to personalised drug discovery
Hussain, M., Stutchbury, B., Tian, K., Çetin-Atalay, R., Schwartz, J., & Krstic–Demonacos, M. (2014) · Research Explorer (The University of Manchester) · Cited by 2
Oral Lichen Planus Studies of factors involved in differentiation, epithelial mesenchymal transition
Danielsson, K. (2012) · Cited by 2
Cutaneous immunohistochemical staining pattern of p53β isoforms
Ko, C. J., Myung, P. S., Leffell, D. J., & Bourdon, J. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205098 · Cited by 2
Self-citation
A Study of P53 Gene and its Regulatory Genes Network
Das, J. K., Ghosh, S., Rout, R. K., & Choudhury, P. P. (2018) · International Conference on Cloud Computing, Data Science & Engineering (Confluence) · doi:10.1109/confluence.2018.8442820 · Cited by 2
CHARACTERIZATION OF THE DWNN DOMAIN AND RING FINGER-LIKE MOTIF WITHIN THE DCM OF THE Drosophila melanogaster SNAMA PROTEIN
Antunes, R. (2008) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 2
Identification of proteins that interact with DWNN domain of SNAMA a member of a novel protein superfamily
Rakgotho, P. M. (2008) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 2
How Does Bacterial Pathogen Helicobacter Pylori Control Responses to Cellular Stress?
Horvat, A., & Zaika, A. I. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0220 · Cited by 2
Small Interfering RNA (siRNA) for Cardiorenal Disease: Mechanistic Insights from Preclinical and Clinical Studies
Wadehra, S., Singh, S., Kaur, S., Kaur, A., & Singh, T. G. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10649-4 · Cited by 1
Δ133p53 isoform enhances TLR4 function to promote tumor growth
Lekamlage, S. P., Jesus, A. N. B. D., Saraiva, A. M., Drummond, C. J., Dolan, H., de Ribot, F. M., Royds, J. A., Mehta, S. Y., Braithwaite, A. W., Hung, N. A., et al. (2025) · Carcinogenesis · doi:10.1093/carcin/bgaf051 · Cited by 1
Exon 4 and intron 4 TP53 are both methylated in advanced‑stage ovarian carcinomas
Szewczuk, W., Szewczuk, O., Czajkowski, K., Gromadka, R., Walędziak, M. S., Semczuk, M., & Semczuk, A. (2025) · Biomedical Reports · doi:10.3892/br.2025.2054 · Cited by 1
The molecular mechanisms and therapeutic potential of p53 in kidney injury repair: a perspective on the p53alpha/delta133p53alpha signaling axis
Fan, J., Guo, Y., Cui, G., Li, Q., Zhang, N., Tao, S., Wu, H., & Zhang, G. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2586388 · Cited by 1
TP53 Splice Mutations Have Tumour-Independent Effects on Genomic Stability and Prognosis: An In Silico Study
Bhandarkar, A. A., Kelly-Foleni, N. E., Sarkar, D., Jeffs, A. R., Slatter, T. L., Braithwaite, A. W., & Mehta, S. Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412080 · Cited by 1
Noc1 downregulation induces nucleolar stress and upregulates p53 isoforms, with a robust increase of the truncated p53E isoform in Drosophila wing discs
Cuda, A. V., Bajaj, S., Manara, V., & Bellosta, P. (2026) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkaf313 · Cited by 1
Regulation of oncogenic C-terminal truncated p53β protein isoform expression by SRSF3–UPF1 splicing and surveillance axis
Jeong, J., Hong, D., Park, T. Y., Hur, J., Koo, T., & Jeong-Yu, S. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01556-5 · Cited by 2
Transcription-dependent and -independent functions of Drosophila p53 isoforms in the induction of apoptosis and senescence-associated tumorigenesis
Perez-Aguilera, M., Ruiz-Losada, M., Gil-Cortés, P., Benchaib, M., Rubio, C., Baena-López, L. A., Baonza, A., & Estella, C. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08571-x · Cited by 1
Biology of p53 protein isoforms and their significance in hematological malignancies
Janik, A. M., Tracz‐Gaszewska, Z., Misiewicz-Krzemińska, I., & Jamroziak, K. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1854189 · Cited by 1
Targeting p53 in Cancer: Functional States, Therapeutic Strategies, and Clinical Progress
Saunders, A., Barkin, J., Karnezis, A. N., & Chien, J. (2026) · Cancers · doi:10.3390/cancers18121861 · Cited by 1
p53: Point Mutations, SNPs and Cancer
Fang, M., Simeonova, I., & Toledo, F. (2012) · InTech eBooks · doi:10.5772/33715 · Cited by 1
MOLECULAR GENETICS OF SOFT TISSUE TUMORS
Lasota, J. P. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781049.006 · Cited by 1
The use of Alu I to destroy DNA contamination in reverse transcription polymerase chain reaction and its advantages
Wang, T., Tsai, Y., & Au, L. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.04.003 · Cited by 1
TP53 isoform junction reads based analysis in malignant and normal contexts
Vural, S., Chang, L., Yee, L. M., & Sonkin, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-96700-1 · Cited by 1
p53
Tsai, W., & Barton, M. C. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_23 · Cited by 1
PICT ‐1 regulates p53 splicing and sensitivity of medullary thyroid carcinoma cells to everolimus
Bareli, Y., Shimon, I., Tobar, A., & Rubinfeld, H. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13187 · Cited by 1
Medulloblastoma, Primitive Neuroectodermal Tumors, and Pineal Tumors
Sandberg, A. A., & Stone, J. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-510-7_8 · Cited by 1
Role of TP53 Mutations in Cancer (An Overview)
Toledo, F. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8442-3_5 · Cited by 1
Molecular Pathology of Lung Tumors
Popper, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-55743-0_19 · Cited by 1
p 53 Family Pathway in Cancer
Bourdon, J., & Lane, D. P. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap223 · Cited by 1
Self-citation
Role of P73 and P53 in the biology of neural stem cells and in the architecture of the neurogenic niches in mouse brain
González-Cano, L. (2013) · Dialnet (Universidad de la Rioja) · Cited by 1
Insights from a novel p53 isoform in zebrafish want to reel us in, but will we take the bait?: Figure 1.Preprint
Manfredi, J. J. (2009) · Genes & Development · doi:10.1101/gad.1778309 · Cited by 1
Biomarcadores genéticos na hemorragia subaracnoidea aneurismática em pacientes da Amazônia
Paschoal, E. H. A. (2017) · doi:10.11606/t.5.2017.tde-10112017-125704 · Cited by 1
Inhibition of nonsense-mediated decay rescues functional p53β/γ isoforms in MDM2-amplified cancersPreprint
Gudikote, J. P., Cascone, T., Poteete, A., Sitthideatphaiboon, P., Wu, Q., Morikawa, N., Zhang, F., Peng, S., Tong, P., Li, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.06.026955 · Cited by 1
Self-citation
Δ40p53 plays a distinct regulatory role in maintaining cellular homeostasis by controlling SGSH expression via miR-4651-5pPreprint
Pal, A., Ghosh, P. K., Ghosh, S., Tripathi, S. K., Patra, S., Khan, D., Maitra, A., & Das, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.04.535506 · Cited by 1
SYNTHETIC LETHALITY OF CDK INHIBITION AND DOXORUBICIN IN TRIPLE-NEGATIVE BREAST CANCER REQUIRES P53 INACTIVATION
Jabbour-Leung, N. A. (2015) · Digital Commons-TMC (Texas Medical Center)
Genetic studies on recurrent miscarriage
Kaare, M. (2009) · Työväentutkimus Vuosikirja
Integration of Genomics and Proteomics in Dissecting p53 Signaling
Lee, K., Wang, T., Rehman, A., Wang, Y., & Daoud, S. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-169-7_2
Role of P73 in endothelial cell differentation, vasculogenesis and angiogenesis
Alonso, R. F. (2013) · Buleria (Universidad de León) · doi:10.18002/10612/2882
Regulation of the p53 Tumor‐Suppressor Protein by Ubiquitin and Ubiquitin‐Like Molecules
Xirodimas, D. P. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch2c
Self-citation
Mecanismos de reparo de DNA envolvidos com lesões induzidas por agente alquilante (Nimustina) em células humanas e sua associação com a resistência de gliomas.
Vilar, J. B. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-24022015-105346
Oncomorphic Tp53 mutations in advanced serous ovarian carcinomas
Brachova, P. (2014) · doi:10.17077/etd.b37fmfpv
Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7
Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
NEW TARGET GENES FOR TUMOR SUPPRESSORS p53 AND p73 IN REGENERATING LIVER
Kurinna, S. M. (2010) · Digital Commons-TMC (Texas Medical Center)
Prostaglandins and angiogenesis in experimental cancer
Axelsson, H. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University)
To reactivate or not to reactivate : Control of KSHV lytic replication is essential for apoptosis in response to p53 restoration
Sarek, G. (2010) · Työväentutkimus Vuosikirja
Análise imunoistoquímica das proteínas maspin, p63 e bcl2 em tumor odontogênico queratocístico, cisto dentígero e ameloblastoma
da Costa, A. F. (2007) · doi:10.11606/d.23.2007.tde-13082007-162555

Authors: Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P.
Affiliations: University of Dundee (GB)
ORCID: Bourdon, Jean-Christophe
Fernandes, Kenneth
Liu, Geng
Xirodimas, Dimitris P.
Saville, Mark K.
Lane, David P.
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2005-08-30
Volume: 19
Issue: 18
Pages: 2122-2137
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.1339905
PMC: PMC1221884
OpenAlex: W2155570392
Cited by: 810
References: 43
Citations by year: 2026: 19 · 2025: 30 · 2024: 26 · 2023: 30 · 2022: 25 · 2021: 37 · 2020: 29 · 2019: 28 · 2018: 41 · 2017: 27 · 2016: 40 · 2015: 27 · 2014: 49 · 2013: 38 · 2012: 48
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (publishedVersion)
HAL (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Genes
Funders: Medical Research Council
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: p53 isoforms, alternative promoters, p73, p63, Δ133p53, dominant-negative p53, p53 transcriptional activity, breast tumors, Drosophila, apoptosis, cancer drug sensitivity
MeSH terms: Animals, Breast Neoplasms, Drosophila, Humans, Introns, Luciferases, Promoter Regions, Genetic, RNA, Messenger, Transcription, Genetic, Genetic Variation, Gene Expression Regulation, Neoplastic, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Genes, Insect, Alternative Splicing, Genes, Reporter, HT29 Cells, Evolution, Molecular, Protein Isoforms, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 isoforms can regulate p53 transcriptional activity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks